Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01659138 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Phase 2 study, sponsored by Sanofi.
- Terminated
- Registry status
- Phase 2
- Development phase
- 28
- Enrollment target
NCT01659138 is a Phase 2 study that was terminated before completion, run by Sanofi. The registered enrollment target is 28 participants.
The verdict
NCT01659138, a Phase 2 study, was terminated before completion, sponsored by Sanofi.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 28 participants
- Enrollment target
Study Summary
Primary Objective: To assess the efficacy of SAR339658 Secondary Objective: To assess the safety of SAR339658
Interventions
- OTHER Placebo
- DRUG SAR339658
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01659138
The ClinicalTrials.gov registry entry for NCT01659138 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01659138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01659138 about?
NCT01659138 is a clinical study titled "Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis". Primary Objective: To assess the efficacy of SAR339658 Secondary Objective: To assess the safety of SAR339658
What is the current status of trial NCT01659138?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 28 participants. The study started on 2012-08. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01659138?
The interventions under investigation include: Placebo (OTHER), SAR339658 (DRUG).
Who is sponsoring clinical trial NCT01659138?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.